Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have shown significant effectiveness in both lowering blood sugar levels and aiding weight loss due to their unique pharmacological mechanisms.
Genetic study demonstrates fat-selective weight loss with GLP-1 agonist use
- Post author:admin
- Post published:February 25, 2025
- Post category:uncategorized